ATE466575T1 - Ibuprofen-lösung für hartschalenkapseln - Google Patents

Ibuprofen-lösung für hartschalenkapseln

Info

Publication number
ATE466575T1
ATE466575T1 AT03743950T AT03743950T ATE466575T1 AT E466575 T1 ATE466575 T1 AT E466575T1 AT 03743950 T AT03743950 T AT 03743950T AT 03743950 T AT03743950 T AT 03743950T AT E466575 T1 ATE466575 T1 AT E466575T1
Authority
AT
Austria
Prior art keywords
ibuprofen solution
hardshell
capsules
hardshell capsules
ibuprofen
Prior art date
Application number
AT03743950T
Other languages
English (en)
Inventor
E M Guillard
Nicolas Madit
Robert A Scott
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE466575T1 publication Critical patent/ATE466575T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT03743950T 2002-03-11 2003-02-28 Ibuprofen-lösung für hartschalenkapseln ATE466575T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290595A EP1344523A1 (de) 2002-03-11 2002-03-11 Ibuprofenlösung für Hartgelatinekapseln
PCT/IB2003/000796 WO2003075909A1 (en) 2002-03-11 2003-02-28 Ibuprofen solution for hard shell capsules

Publications (1)

Publication Number Publication Date
ATE466575T1 true ATE466575T1 (de) 2010-05-15

Family

ID=27763452

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03743950T ATE466575T1 (de) 2002-03-11 2003-02-28 Ibuprofen-lösung für hartschalenkapseln

Country Status (15)

Country Link
US (1) US7229639B2 (de)
EP (2) EP1344523A1 (de)
JP (2) JP4818587B2 (de)
KR (1) KR100679582B1 (de)
CN (1) CN1642537A (de)
AT (1) ATE466575T1 (de)
AU (1) AU2003215775A1 (de)
BR (1) BR0308348A (de)
CA (1) CA2477393A1 (de)
DE (1) DE60332432D1 (de)
EA (1) EA200401067A1 (de)
ES (1) ES2342825T3 (de)
MX (1) MXPA04008151A (de)
NZ (1) NZ534928A (de)
WO (1) WO2003075909A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344523A1 (de) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofenlösung für Hartgelatinekapseln
SI2279729T1 (sl) * 2003-07-17 2016-10-28 Banner Life Sciences, LLC Pripravki z nadziranim sproščanjem
US20070071808A1 (en) * 2003-08-28 2007-03-29 Janik John J Capsule filled with honey
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
AU2005206084A1 (en) * 2004-01-09 2005-08-04 Wyeth Microemulsions for pharmaceutical compositions
US20080075767A1 (en) * 2006-06-30 2008-03-27 Jin Xiao P Ibuprofen-containing liquid filled hard capsules
KR101236528B1 (ko) * 2010-06-07 2013-02-22 한국콜마주식회사 덱시부프로펜 액상 조성물을 함유하는 밀봉된 경질캡슐제
KR101346750B1 (ko) * 2010-06-07 2013-12-31 한국콜마주식회사 나프록센 액상 조성물을 함유하는 밀봉된 경질캡슐제
US9044394B2 (en) * 2010-10-18 2015-06-02 PruGen IP Holdings, Inc. Bioavailability enhancement delivery composition
JP6219836B2 (ja) 2011-11-09 2017-10-25 キャプシュゲル・ベルジウム・エヌ・ヴィ 耐酸性ツーピースハードカプセル用の耐酸性バンディング溶液
EP3566699A1 (de) 2015-11-10 2019-11-13 Capsugel Belgium NV Säurebeständige bändelungs- oder dichtungslösung für säurebeständige zweiteilige hartkapseln
WO2018008660A1 (ja) * 2016-07-06 2018-01-11 クオリカプス株式会社 硬度が改善された硬質カプセル、及びその製造方法
US20210369625A1 (en) * 2018-10-02 2021-12-02 Qualicaps Co., Ltd. Improved-strength hard capsule and production method for same
EP3863603A1 (de) 2018-10-08 2021-08-18 Chanelle Pharmaceuticals Manufacturing Ltd. Weichgelkapselformulierung, verfahren zu ihrer herstellung und ihre verwendung
GB2595453B (en) * 2020-05-21 2024-04-03 Reckitt Benckiser Health Ltd Novel Formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5831108A (en) * 1995-08-03 1998-11-03 California Institute Of Technology High metathesis activity ruthenium and osmium metal carbene complexes
GB9605948D0 (en) * 1996-03-21 1996-05-22 Smithkline Beecham Plc Novel formulations
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
US6221391B1 (en) * 1998-11-23 2001-04-24 Accucaps Industries Limited Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition
EP1344523A1 (de) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofenlösung für Hartgelatinekapseln

Also Published As

Publication number Publication date
ES2342825T3 (es) 2010-07-15
BR0308348A (pt) 2005-01-25
WO2003075909A1 (en) 2003-09-18
CA2477393A1 (en) 2003-09-18
US7229639B2 (en) 2007-06-12
NZ534928A (en) 2006-09-29
JP4818587B2 (ja) 2011-11-16
CN1642537A (zh) 2005-07-20
JP2009197015A (ja) 2009-09-03
KR100679582B1 (ko) 2007-02-07
JP2005526758A (ja) 2005-09-08
EP1344523A1 (de) 2003-09-17
AU2003215775A1 (en) 2003-09-22
DE60332432D1 (de) 2010-06-17
KR20040101300A (ko) 2004-12-02
EP1485081A1 (de) 2004-12-15
MXPA04008151A (es) 2004-11-26
US20030211145A1 (en) 2003-11-13
EP1485081B1 (de) 2010-05-05
EA200401067A1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
ATE466575T1 (de) Ibuprofen-lösung für hartschalenkapseln
NO20053150D0 (no) System for administrasjon av medisin.
NO20014035L (no) System for oral administrasjon av medikament
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
IS7755A (is) Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
ITBO20020693A0 (it) Sistema di macchina imballatrice, del tipo a manica, particolarmente indicato per l'esecuzione del cambio bobina.
ITMI20031867A1 (it) Procedimento per riempire contenitori farmaceutici come ampolle, fiale o similari.
DK1494650T3 (da) Farmaceutisk formulering, der indeholder melatonin
ITMI20021766A1 (it) Scatola con tasca per foglietto illustrativo, facilmente confezionabile
NO20052975D0 (no) Nye 2',5'-oligoadenylsyreanaloger.
NO20064783L (no) Opplosningstabeletter med licarbazepin
ATE355830T1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
IT1320053B1 (it) Telaio scocca per motociclo.
ITTO20030240A1 (it) Ruota per motociclo.
ITMI20011718A0 (it) Processo per la preparazione del sale sodico dell'acido-6(d-(-)-alpha-(4-etil-2,3-diosso-1-piperazinocarbonilammino)fenilacetammido)penicill
IT1307348B1 (it) Struttura di contenimento sotto-sella per motocicletta del tiposcooter.
ITFI20020246A1 (it) Contenitore sterile.
SK3492U (sk) Hlavové zloženie, najmä na bicykle
ZA200603048B (en) 1-2'(1,4'-Biperidin-1'-yl)-1-(phenyl)ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
ECSP982747A (es) Nuevas formulaciones del antidepresivo paroxetina
ITMO20030100A0 (it) Dispositivo per la separazione di pillole,capsule o simili.
ITBO20030786A1 (it) Contenitore frangibile per attivita' ludica.
ITTS20020011U1 (it) Utensile per asportare la sommita' del guscio delle uova.
ITTV20020107A1 (it) Calzatura sportiva, particolarmente per il motociclismo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties